{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:39:03Z","timestamp":1787690343377,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The effect of coupled plasma filtration adsorption (CPFA) for the treatment of sepsis or septic shock is controversial. A systematic review and meta-analysis was performed to evaluate the impact of CPFA on all-cause mortality in patients with sepsis or septic shock.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We searched the PubMed, Cochrane, and Embase databases for randomized controlled trials (RCTs) and cohort studies from inception to the 1st of May 2022. We included studies involving patients (\u02c3\u00a014\u00a0years) with sepsis or septic shock. All authors reported our primary outcome of all-cause mortality (hospital mortality, 28-day mortality or 30-day mortality). Results were expressed as odds ratio (OR) with accompanying 95% confidence interval (CI).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Six studies including 537 patients were included. The primary outcome of this meta-analysis showed that the all-cause mortality was about 54.2% (119\/243 in the CPFA group and 172\/294 in the control group). There was no statistically significant difference in the all-cause mortality between two groups (odds ratio [OR]\u2009=\u20090.75; 95% CI 0.53 to 1.06; P\u2009=\u20090.11; Chi<jats:sup>2<\/jats:sup>\u2009=\u200914.04; I<jats:sup>2<\/jats:sup>\u2009=\u200964%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The treatment of CPFA failed to decrease all-cause mortality of sepsis or septic shock patients. Further large-scale randomized controlled trials (RCTs) evaluating the ability of this therapy to improve clinical outcomes are still required to confirm these results.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07689-5","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T11:02:55Z","timestamp":1661770975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Coupled plasma filtration adsorption for the treatment of sepsis or septic shock: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Yuting","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"issue":"10","key":"7689_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1164\/rccm.201310-1875OC","volume":"189","author":"A Leligdowicz","year":"2014","unstructured":"Leligdowicz A, Dodek PM, Norena M, Wong H, Kumar A, Kumar A, Co-operative Antimicrobial Therapy of Septic Shock Database Research Group. Association between source of infection and hospital mortality in patients who have septic shock. Am J Respir Crit Care Med. 2014;189(10):1204\u201313.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"7689_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/jama.2014.5804","volume":"312","author":"V Liu","year":"2014","unstructured":"Liu V, Escobar GJ, Greene JD, Soule J, Whippy A, Angus DC, et al. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA. 2014;312(1):90\u20132.","journal-title":"JAMA"},{"issue":"10","key":"7689_CR3","first-page":"1808","volume":"10","author":"G Camussi","year":"1995","unstructured":"Camussi G, Montrucchio G, Dominioni L, Dionigi R. Septic shock: the unravelling of molecular mechanisms. Nephrol Dial Transplant. 1995;10(10):1808\u201313.","journal-title":"Nephrol Dial Transplant"},{"key":"7689_CR4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1159\/000060100","volume":"132","author":"MR Pinsky","year":"2001","unstructured":"Pinsky MR. Sepsis: a pro- and anti-inflammatory disequilibrium syndrome. Contrib Nephrol. 2001;132:354\u201366.","journal-title":"Contrib Nephrol"},{"issue":"1","key":"7689_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/labinvest.2013.110","volume":"94","author":"EG King","year":"2014","unstructured":"King EG, Bauz\u00e1 GJ, Mella JR, Remick DG. Pathophysiologic mechanisms in septic shock. Lab Invest. 2014;94(1):4\u201312.","journal-title":"Lab Invest"},{"issue":"5","key":"7689_CR6","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/nm0509-496","volume":"15","author":"RS Hotchkiss","year":"2009","unstructured":"Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA. The sepsis seesaw: tilting toward immunosuppression. Nat Med. 2009;15(5):496\u20137.","journal-title":"Nat Med"},{"issue":"Suppl 4","key":"7689_CR7","doi-asserted-by":"publisher","first-page":"S474","DOI":"10.1007\/BF01743727","volume":"22","author":"HD Volk","year":"1996","unstructured":"Volk HD, Reinke P, Krausch D, Zuckermann H, Asadullah K, M\u00fcller JM, et al. Monocyte deactivation: rationale for a new therapeutic strategy in sepsis. Intensive Care Med. 1996;22(Suppl 4):S474\u201381.","journal-title":"Intensive Care Med"},{"issue":"1","key":"7689_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1084\/jem.184.1.51","volume":"184","author":"P Brandtzaeg","year":"1996","unstructured":"Brandtzaeg P, Osnes L, Ovsteb\u00f8 R, Jo\u00f8 GB, Westvik AB, Kierulf P. Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes. J Exp Med. 1996;184(1):51\u201360.","journal-title":"J Exp Med"},{"issue":"5","key":"7689_CR9","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1164\/ajrccm.162.5.2003058","volume":"162","author":"M Adib-Conquy","year":"2000","unstructured":"Adib-Conquy M, Adrie C, Moine P, Asehnoune K, Fitting C, Pinsky MR, et al. NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance. Am J Respir Crit Care Med. 2000;162(5):1877\u201383.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"7689_CR10","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1093\/ndt\/13.6.1458","volume":"13","author":"C Tetta","year":"1998","unstructured":"Tetta C, Cavaillon JM, Schulze M, Ronco C, Ghezzi PM, Camussi G, et al. Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption. Nephrol Dial Transplant. 1998;13(6):1458\u201364.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"7689_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/00003643-200001000-00003","volume":"17","author":"K Reinhart","year":"2000","unstructured":"Reinhart K, Sakka SG, Meier-Hellmann A. Haemodynamic management of a patient with septic shock. Eur J Anaesthesiol. 2000;17(1):6\u201317.","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"7689_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/cc9411","volume":"15","author":"T Rimmel\u00e9","year":"2011","unstructured":"Rimmel\u00e9 T, Kellum JA. Clinical review: blood purification for sepsis. Crit Care. 2011;15(1):205.","journal-title":"Crit Care"},{"issue":"5","key":"7689_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/0885066611425759","volume":"28","author":"A Panagiotou","year":"2013","unstructured":"Panagiotou A, Gaiao S, Cruz DN. Extracorporeal therapies in sepsis. J Intensive Care Med. 2013;28(5):281\u201395.","journal-title":"J Intensive Care Med"},{"issue":"3","key":"7689_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000490234","volume":"46","author":"G La Manna","year":"2018","unstructured":"La Manna G, Donati G. Coupled plasma filtration adsorption: a multipurpose extracorporeal detoxification therapy. Blood Purif. 2018;46(3):228\u201338.","journal-title":"Blood Purif"},{"key":"7689_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jcrc.2016.02.005","volume":"33","author":"M Franchi","year":"2016","unstructured":"Franchi M, Giacalone M, Traupe I, Rago R, Baldi G, Giunta F, et al. Coupled plasma filtration adsorption improves hemodynamics in septic shock. J Crit Care. 2016;33:100\u20135.","journal-title":"J Crit Care"},{"issue":"5","key":"7689_CR16","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00134-003-1724-0","volume":"29","author":"M Formica","year":"2003","unstructured":"Formica M, Olivieri C, Livigni S, Cesano G, Vallero A, Maio M, et al. Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock. Intensive Care Med. 2003;29(5):703\u20138.","journal-title":"Intensive Care Med"},{"key":"7689_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","volume":"134","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol. 2021;134:178\u201389.","journal-title":"J Clin Epidemiol"},{"key":"7689_CR18","unstructured":"Higgins JPT, Sally G. Cochrane handbook for systematic reviews of interventions, version 5.1.0. 2016. http:\/\/training.cochrane.org\/handbook. Accessed 23 Dec 2016."},{"key":"7689_CR19","first-page":"727","volume":"18","author":"GA Wells","year":"2014","unstructured":"Wells GA, Shea BJ, O\u2019connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Appl Eng Agric. 2014;18:727\u201334.","journal-title":"Appl Eng Agric"},{"issue":"29","key":"7689_CR20","doi-asserted-by":"publisher","first-page":"6093","DOI":"10.1002\/sim.3428","volume":"27","author":"BJ Biggerstaff","year":"2008","unstructured":"Biggerstaff BJ, Jackson D. The exact distribution of Cochran\u2019s heterogeneity statistic in one-way random effects meta-analysis. Stat Med. 2008;27(29):6093\u2013110.","journal-title":"Stat Med"},{"key":"7689_CR21","first-page":"681","volume":"12","author":"J Hassan","year":"2013","unstructured":"Hassan J, Cader RA, Kong NC, Mohd M, Rahman AR, Hod R. Coupled plasma filtration adsorption (CPFA) plus continuous veno-venous haemofiltration (CVVH) versus CVVH alone as an adjunctive therapy in the treatment of sepsis. EXCLI J. 2013;12:681\u201392.","journal-title":"EXCLI J"},{"issue":"1","key":"7689_CR22","doi-asserted-by":"publisher","first-page":"e003536","DOI":"10.1136\/bmjopen-2013-003536","volume":"4","author":"S Livigni","year":"2014","unstructured":"Livigni S, Bertolini G, Rossi C, Ferrari F, Giardino M, Pozzato M, GiViTI: Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva, et al. Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: a multicenter randomised controlled clinical trial. BMJ Open. 2014;4(1):e003536.","journal-title":"BMJ Open"},{"issue":"1\u20133","key":"7689_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1159\/000371754","volume":"39","author":"M Yaroustovsky","year":"2015","unstructured":"Yaroustovsky M, Abramyan M, Krotenko N, Popov D, Plyushch M, Rogalskaya E. A pilot study of selective lipopolysaccharide adsorption and coupled plasma filtration and adsorption in adult patients with severe sepsis. Blood Purif. 2015;39(1\u20133):210\u20137.","journal-title":"Blood Purif"},{"issue":"12","key":"7689_CR24","doi-asserted-by":"publisher","first-page":"e030139","DOI":"10.1136\/bmjopen-2019-030139","volume":"9","author":"C Gim\u00e9nez-Esparza","year":"2019","unstructured":"Gim\u00e9nez-Esparza C, Portillo-Requena C, Colomina-Climent F, Allegue-Gallego JM, Galindo-Mart\u00ednez M, Moll\u00e0-Jim\u00e9nez C, et al. The premature closure of ROMPA clinical trial: mortality reduction in septic shock by plasma adsorption. BMJ Open. 2019;9(12):e030139.","journal-title":"BMJ Open"},{"issue":"1","key":"7689_CR25","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.burns.2019.05.017","volume":"46","author":"F Mariano","year":"2020","unstructured":"Mariano F, Hollo\u2019 Z, Depetris N, Malvasio V, Mella A, Bergamo D, et al. Coupled-plasma filtration and adsorption for severe burn patients with septic shock and acute kidney injury treated with renal replacement therapy. Burns. 2020;46(1):190\u20138.","journal-title":"Burns"},{"issue":"11","key":"7689_CR26","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00134-021-06501-3","volume":"47","author":"E Garbero","year":"2021","unstructured":"Garbero E, Livigni S, Ferrari F, Finazzi S, Langer M, Malacarne P, GiViTI, et al. High dose coupled plasma filtration and adsorption in septic shock patients Results of the COMPACT-2: a multicentre, adaptive, randomised clinical trial. Intensive Care Med. 2021;47(11):1303\u201311.","journal-title":"Intensive Care Med"},{"issue":"3","key":"7689_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000047022","volume":"20","author":"R Bellomo","year":"2002","unstructured":"Bellomo R, Tetta C, Brendolan A, Ronco C. Coupled plasma filtration adsorption. Blood Purif. 2002;20(3):289\u201392.","journal-title":"Blood Purif"},{"issue":"6","key":"7689_CR28","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/00003246-200206000-00015","volume":"30","author":"C Ronco","year":"2002","unstructured":"Ronco C, Brendolan A, Lonnemann G, Bellomo R, Piccinni P, Digito A, et al. A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med. 2002;30(6):1250\u20135.","journal-title":"Crit Care Med"},{"issue":"5","key":"7689_CR29","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/SHK.0b013e318188dec5","volume":"31","author":"R Sykora","year":"2009","unstructured":"Sykora R, Chvojka J, Krouzecky A, Radej J, Kuncova J, Varnerova V, et al. Coupled plasma filtration adsorption in experimental peritonitis-induced septic shock. Shock. 2009;31(5):473\u201380.","journal-title":"Shock"},{"issue":"3","key":"7689_CR30","first-page":"258","volume":"20","author":"G Cesano","year":"2003","unstructured":"Cesano G, Livigni S, Vallero A, Olivieri C, Borca M, Quarello F, et al. Treatment of septic shock with the use of CPFA (associated plasma filtration and adsorption): impact on hemodynamics monitored with PiCCO. G Ital Nefrol. 2003;20(3):258\u201363.","journal-title":"G Ital Nefrol"},{"issue":"Suppl 1","key":"7689_CR31","first-page":"S93","volume":"27","author":"Carlet J; International Sepsis Forum","year":"2001","unstructured":"Carlet J; International Sepsis Forum. Immunological therapy in sepsis: currently available. Intensive Care Med. 2001;27(Suppl 1):S93-103.","journal-title":"Intensive Care Med"},{"issue":"10","key":"7689_CR32","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1097\/00003246-199910000-00003","volume":"27","author":"JH Reeves","year":"1999","unstructured":"Reeves JH, Butt WW, Shann F, Layton JE, Stewart A, Waring PM, et al. Continuous plasmafiltration in sepsis syndrome. Crit Care Med. 1999;27(10):2096\u2013104.","journal-title":"Crit Care Med"},{"issue":"10","key":"7689_CR33","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1007\/s00134-002-1410-7","volume":"28","author":"R Busund","year":"2002","unstructured":"Busund R, Koukline V, Utrobin U, Nedashkovsky E. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med. 2002;28(10):1434\u20139.","journal-title":"Intensive Care Med"},{"issue":"3","key":"7689_CR34","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","volume":"45","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486\u2013552.","journal-title":"Crit Care Med"},{"issue":"1","key":"7689_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/MAT.0000000000000009","volume":"60","author":"M Page","year":"2014","unstructured":"Page M, Cohen S, Ber CE, Allaouchiche B, Kellum JA, Rimmel\u00e9 T. In vivo antibiotic removal during coupled plasma filtration adsorption: a retrospective study. ASAIO J. 2014;60(1):70\u20135.","journal-title":"ASAIO J"},{"issue":"7","key":"7689_CR36","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10096-019-03529-8","volume":"38","author":"M Andersson","year":"2019","unstructured":"Andersson M, \u00d6stholm-Balkhed \u00c5, Fredrikson M, Holmbom M, H\u00e4llgren A, Berg S, et al. Delay of appropriate antibiotic treatment is associated with high mortality in patients with community-onset sepsis in a Swedish setting. Eur J Clin Microbiol Infect Dis. 2019;38(7):1223\u201334.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"7689_CR37","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/CCM.0000000000002264","volume":"45","author":"CW Seymour","year":"2017","unstructured":"Seymour CW, Kahn JM, Martin-Gill C, Callaway CW, Yealy DM, Scales D, et al. Delays from first medical contact to antibiotic administration for Sepsis. Crit Care Med. 2017;45(5):759\u201365.","journal-title":"Crit Care Med"},{"issue":"11","key":"7689_CR38","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1097\/CCM.0000000000000509","volume":"42","author":"SL Weiss","year":"2014","unstructured":"Weiss SL, Fitzgerald JC, Balamuth F, Alpern ER, Lavelle J, Chilutti M, et al. Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis. Crit Care Med. 2014;42(11):2409\u201317.","journal-title":"Crit Care Med"},{"issue":"10","key":"7689_CR39","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00134-019-05707-w","volume":"45","author":"A Douvris","year":"2019","unstructured":"Douvris A, Zeid K, Hiremath S, Bagshaw SM, Wald R, Beaubien-Souligny W, et al. Mechanisms for hemodynamic instability related to renal replacement therapy: a narrative review. Intensive Care Med. 2019;45(10):1333\u201346.","journal-title":"Intensive Care Med"},{"issue":"6","key":"7689_CR40","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1186\/s13054-014-0624-8","volume":"18","author":"JA Silversides","year":"2014","unstructured":"Silversides JA, Pinto R, Kuint R, Wald R, Hladunewich MA, Lapinsky SE, et al. Fluid balance, intradialytic hypotension, and outcomes in critically ill patients undergoing renal replacement therapy: a cohort study. Crit Care. 2014;18(6):624.","journal-title":"Crit Care"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07689-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07689-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07689-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T11:03:48Z","timestamp":1661771028000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07689-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7689"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07689-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,29]]},"assertion":[{"value":"7 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"714"}}